The LASSO regression model and survival analysis further suggested that two hub genes (PAMR1 and SLC24A3) could serve as potential biomarkers for the treatment or diagnosis of cervical and endometrial cancers. The gene discussed is SLC24A3; the disease is endometrial cancer.